Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastrointestinal Cancers
•
Gastroenterology
•
General Hepatology
How would you approach the workup of a patient with a history of HCC post-TARE with a recent non-viable MRI but a new portal vein thrombosis?
Related Questions
Do you obtain liver biopsy to confirm the diagnosis of cirrhosis if cirrhotic liver morphology is noted on imaging?
How long do you recommend waiting after variceal bleeding and banding before a transesophageal echocardiogram can be performed safely?
Do you avoid peritoneal dialysis in cirrhotic patients with ascites?
What are your top takeaways from AASLD 2025?
At what BMI or waist-circumference threshold do you opt to move from Fibroscan to other NILDA for fibrosis assessment?
How do you plan to integrate exercise programs after adjuvant chemotherapy in patients with colon cancer, given the results of the CHALLENGE trial?
When starting Rezdiffra (resmetirom) what labs do you get for monitoring and at what interval?
How do you approach HCC screening in patients with advanced fibrosis e.g., F3 on FibroScan?
Do you recommend starting naltrexone at discharge for alcohol use disorder in patients with decompensated cirrhosis secondary to alcohol use?
Which GI cancer patients do you use oral contrast in staging CT scans?
